In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price ...

In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

HC Wainwright reissued their buy rating on shares of Alumis (NASDAQ:ALMS – Free Report) in a report published on Monday,Benzinga reports. They currently have a $19.00 price objective on the stock. A ...

They’ve been a model of social housing since the Middle Ages but almshouses are suffering from the unintended consequences of ...

Friday marks three weeks since Pope Francis was hospitalized for bronchitis, which then led to double pneumonia.

Acelyrin (NASDAQ:SLRN) announced Thursday a decision to adopt a limited-duration stockholder rights plan, also known as a poison pill, after Tang Capital Partners rapidly accumulated 8.8% of the ...

At the traffic junction at ITO in central Delhi, a girl in a torn frock weaves through the idling cars, tapping on windows ...

The death toll from Sunday’s tragic stampede at an alms-giving event in Bauchi State has risen to seven, police confirmed on ...